Medicines for Ireland was proud to support the Medicines for Europe Annual Conference, which took place in the Portmarnock Resort & Jameson Golf Links on the 12th and 13th of June. This year, Medicines For Europe celebrated three decades of advocating for equitable access to generic, biosimilar, and value-added medicines. The conference brought together industry experts, policymakers, and healthcare professionals to discuss the latest developments in the field of off-patent medicines. The insightful discussions focused on the future of healthcare and the role of affordable medicines in ensuring patient access.
The conference was opened by President of Medicines for Europe, Elisabeth Stampa, Commissioner for Health and Food safety, European Commission, Stella Kyriakides, and Chairperson of Medicines for Ireland, Paul Neill. All three emphasised the importance of collaboration and innovation in the off-patent medicines industry.
The conference explored:
◾ The value proposition of off-patent medicines is providing cost-effective treatment options.
◾ The evolution of the off-patent sector and solutions for promoting generic medicines in healthcare.
◾ Future supply chain security for critical medicines through robust European regulation.
◾ Opportunities for improving existing treatments and the positive impact of innovation on health system sustainability.
◾ Merging environmental sustainability with better access to medicines.
◾ The future of the off-patent pharmaceutical industry in Europe.
The timing of this conference is important for Medicines for Ireland as an trade association representing members who supplying the majority of medicine in Ireland to the HSE and patients directly. As we prepare to enter negotiations on the Framework Agreement on the Supply and Pricing of Medicines, the conference provided an opportunity for our key stakeholders to hear about the challenges and solutions being implemented across Europe.
MFI Chairperson, Paul Neill and Vice Chairperson, Deirdre Kelly provide a brief overview of the discussions, key takeaways and next steps that MFI will take following the conference in the video below.
